BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10767508)

  • 21. CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy-induced immune depression in uninfected and HIV-infected women.
    Rich KC; Siegel JN; Jennings C; Rydman RJ; Landay AL
    J Infect Dis; 1995 Nov; 172(5):1221-7. PubMed ID: 7594657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women.
    Heffron R; Donnell D; Kiarie J; Rees H; Ngure K; Mugo N; Were E; Celum C; Baeten JM;
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):231-6. PubMed ID: 24442226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers.
    Bunders M; Thorne C; Newell ML;
    AIDS; 2005 Jul; 19(10):1071-9. PubMed ID: 15958839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of nevirapine in HIV-infected pregnant women initiating antiretroviral therapy at higher CD4 counts: a systematic review and meta-analysis.
    Bera E; Mia R
    S Afr Med J; 2012 Oct; 102(11 Pt 1):855-9. PubMed ID: 23116743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral treatment during pregnancy.
    Keiser O; Gayet-Ageron A; Rudin C; Brinkhof MW; Gremlich E; Wunder D; Drack G; Hirschel B; de Tejada BM; ;
    AIDS; 2008 Nov; 22(17):2323-30. PubMed ID: 18981771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological markers in HIV-infected pregnant women. The European Collaborative Study and the Swiss HIV Pregnancy Cohort.
    AIDS; 1997 Dec; 11(15):1859-65. PubMed ID: 9412705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV infection in women: immunological markers and the influence of pregnancy.
    Brettle RP; Raab GM; Ross A; Fielding KL; Gore SM; Bird AG
    AIDS; 1995 Oct; 9(10):1177-84. PubMed ID: 8519455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T lymphocyte subsets during and after pregnancy: analysis in human immunodeficiency virus type 1-infected and -uninfected Malawian mothers.
    Miotti PG; Liomba G; Dallabetta GA; Hoover DR; Chiphangwi JD; Saah AJ
    J Infect Dis; 1992 Jun; 165(6):1116-9. PubMed ID: 1583330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot study on CD4 & CD8 cell counts in healthy HIV seronegative pregnant women.
    Dayama A; Pandit D; Mudaliar S; Bharadwaj R; Bharucha KE; Shrotri AN; Joshi S
    Indian J Med Res; 2003 May; 117():198-200. PubMed ID: 14609046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-10-secreting T cells from HIV-infected pregnant women downregulate HIV-1 replication: effect enhanced by antiretroviral treatment.
    Bento CA; Hygino J; Andrade RM; Saramago CS; Silva RG; Silva AA; Linhares UC; Brindeiro R; Tanuri A; Rosenzwajg M; Klatzmann D; Andrade AF
    AIDS; 2009 Jan; 23(1):9-18. PubMed ID: 19050381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte subset changes between 3 and 15 months of age in infants born to HIV-seropositive women in South Africa.
    Moodley D; Bobat RA; Coovadia HM; Doorasamy T; Munsamy S; Gouws E
    Trop Med Int Health; 1997 May; 2(5):415-21. PubMed ID: 9217696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors.
    St Louis ME; Kamenga M; Brown C; Nelson AM; Manzila T; Batter V; Behets F; Kabagabo U; Ryder RW; Oxtoby M
    JAMA; 1993 Jun; 269(22):2853-9. PubMed ID: 8098783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis E virus infection and fulminant hepatic failure during pregnancy.
    Jilani N; Das BC; Husain SA; Baweja UK; Chattopadhya D; Gupta RK; Sardana S; Kar P
    J Gastroenterol Hepatol; 2007 May; 22(5):676-82. PubMed ID: 17444855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
    N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.
    Myer L; Kamkuemah M; Kaplan R; Bekker LG
    Trop Med Int Health; 2013 Nov; 18(11):1400-5. PubMed ID: 24102663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.
    Weigel R; Hosseinipour MC; Feldacker C; Gareta D; Tweya H; Chiwoko J; Gumulira J; Kalulu M; Mofolo I; Kamanga E; Mwale G; Kadzakumanja A; Jere E; Phiri S
    Trop Med Int Health; 2012 Jun; 17(6):751-9. PubMed ID: 22487553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings.
    Ekouevi DK; Inwoley A; Tonwe-Gold B; Danel C; Becquet R; Viho I; Rouet F; Dabis F; Anglaret X; Leroy V
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1469-74. PubMed ID: 18160003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.